
基本信息:
- 专利标题: PU.1 INHIBITORS
- 申请号:US16227739 申请日:2018-12-20
- 公开(公告)号:US20190112276A1 公开(公告)日:2019-04-18
- 发明人: W. David Wilson , David W. Boykin , Gregory Poon , Ulrich Steidl , Iléana Anthony-Debré
- 申请人: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. , GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
- 申请人地址: US NY Bronx US GA Atlanta
- 专利权人: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.,GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
- 当前专利权人: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.,GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
- 当前专利权人地址: US NY Bronx US GA Atlanta
- 主分类号: C07D235/20
- IPC分类号: C07D235/20 ; C07D401/14 ; C07D409/04 ; A61P35/02
摘要:
Disclosed herein are inhibitors of PU.1. The inhibitors are useful for treating disorders associated with abnormal PU.1 levels and function.
公开/授权文献:
- US10774049B2 PU.1 inhibitors 公开/授权日:2020-09-15
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D235/00 | 杂环化合物,含1,3-二唑或氢化1,3-二唑环、与其他环稠合 |
--------C07D235/02 | .与碳环或碳环系稠合 |
----------C07D235/04 | ..苯并咪唑;氢化苯并咪唑 |
------------C07D235/20 | ...两个苯并咪唑-2基直接相连,或经烃基或取代的烃基而相连 |